TAVI 2: new devices, procedural refinements

Session comprising selected EuroPCR 2023 Abstract submissions

Summary

Seeking a recap of the TAVI Abstract session? Dive into the provided slides containing the main points of the presentation.

Presentations available when logged in:

  • DurAVR TAVI first-in-man study confirms excellent haemodynamics to 1 year
  • Safety and performance of the Vienna TAVI system: six-month follow-up results
  • Delayed assessment of paravalvular regurgitation in TAVI reduces post-dilatation
  • Ultrasound-guided deployment of ProGlide in TAVI. A propensity score study
  • Femoral or radial secondary access in TAVI: subanalysis from the PULSE registry
  • Impact of edoxaban on bioprosthetic leaflet thickening
  • Comparison of different revascularisation timing strategies in TAVI patients